Considered together, these findings suggest that CD8+ lymphocytes may be the main cell immune subpopulation mediating the antitumor activity when Id1sh-LLC tumor-bearing mice are treated with an anti-PD-1 antibody. Here, CD8A is linked to neoplasm.